ATE415387T1 - Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten - Google Patents

Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten

Info

Publication number
ATE415387T1
ATE415387T1 AT03734040T AT03734040T ATE415387T1 AT E415387 T1 ATE415387 T1 AT E415387T1 AT 03734040 T AT03734040 T AT 03734040T AT 03734040 T AT03734040 T AT 03734040T AT E415387 T1 ATE415387 T1 AT E415387T1
Authority
AT
Austria
Prior art keywords
cysteine
benzimidoic
benzonitriles
producing
peptidal
Prior art date
Application number
AT03734040T
Other languages
English (en)
Inventor
Mukund S Chorghade
Mukund K Gurjar
Joseph Cherian
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE415387T1 publication Critical patent/ATE415387T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/04Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
    • C07C257/08Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/06Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols from sulfides, hydropolysulfides or polysulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/12Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT03734040T 2002-05-15 2003-05-15 Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten ATE415387T1 (de)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US38101702P 2002-05-15 2002-05-15
US38101202P 2002-05-15 2002-05-15
US38102102P 2002-05-15 2002-05-15
US38087802P 2002-05-15 2002-05-15
US38089402P 2002-05-15 2002-05-15
US38089502P 2002-05-15 2002-05-15
US38091002P 2002-05-15 2002-05-15
US38088002P 2002-05-15 2002-05-15
US38090302P 2002-05-15 2002-05-15
US38090902P 2002-05-15 2002-05-15
US38101302P 2002-05-15 2002-05-15
US39283302P 2002-06-27 2002-06-27

Publications (1)

Publication Number Publication Date
ATE415387T1 true ATE415387T1 (de) 2008-12-15

Family

ID=29554649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03734040T ATE415387T1 (de) 2002-05-15 2003-05-15 Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten

Country Status (6)

Country Link
US (17) US6794515B2 (de)
EP (2) EP1506162B1 (de)
JP (3) JP2005538950A (de)
AT (1) ATE415387T1 (de)
AU (2) AU2003239472A1 (de)
WO (2) WO2003097622A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500490A1 (de) * 2001-10-16 2006-01-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von substituierten thiazolinen und deren zwischenprodukte
US20080086494A1 (en) * 2006-09-11 2008-04-10 Apple Computer, Inc. Transfer and synchronization of media data
US6794515B2 (en) * 2002-05-15 2004-09-21 Genzyme Corporation Synthesis of 2-alkylcysteine via substituted thiazoline amide
US7394410B1 (en) * 2004-02-13 2008-07-01 Samplify Systems, Inc. Enhanced data converters using compression and decompression
DE602005023466D1 (de) 2004-07-22 2010-10-21 Mitsubishi Gas Chemical Co Asymmetrische l-aminosäureamid-hydrolase und dafür codierende dna
DE102005054362A1 (de) * 2004-12-01 2006-06-08 Degussa Ag Verfahren zur Herstellung von Amino- oder Hydroxybenzonitrilen
EP1866293A1 (de) 2005-03-31 2007-12-19 UCB Pharma, S.A. Eine oxazol- oder thiazolgruppe enthaltende verbindungen, verfahren zu deren herstellung und ihre anwendungen
EA200701852A1 (ru) 2005-04-28 2008-04-28 Пфайзер Лимитед Производные аминокислот
JP2006312614A (ja) * 2005-05-09 2006-11-16 Ajinomoto Co Inc チアゾリン化合物および光学活性α−アルキルシステインの製造方法
US7947837B2 (en) * 2006-10-25 2011-05-24 Polyera Corporation Organic semiconductor materials and methods of preparing and use thereof
WO2009005775A2 (en) * 2007-06-29 2009-01-08 University Of South Florida Enantioselective ring-opening of aziridines
EP2334620B1 (de) * 2008-09-05 2018-09-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur enantioselektiven trennung chiraler systeme mit verbindungsbildung unter anwendung von zwei aufeinanderfolgenden kristallisationsschritten
US8765817B1 (en) 2008-12-03 2014-07-01 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
US8349899B1 (en) 2008-12-03 2013-01-08 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
EP3300717B1 (de) * 2009-06-29 2020-09-23 Inolex Investment Corporation Nichtpetrochemisch gewonnene kationische emulgatoren als neutralisierte aminosäureester und zugehörige zusammensetzungen und verfahren
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
US9279022B1 (en) 2014-09-08 2016-03-08 Sirrus, Inc. Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
WO2012054633A2 (en) * 2010-10-20 2012-04-26 Bioformix, Llc Synthesis of methylene malonates using rapid recovery in the presence of a heat transfer agent
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US9249265B1 (en) 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
JP2014532625A (ja) 2011-10-19 2014-12-08 シラス・インコーポレイテッド メチレンβ−ジケトンモノマー、メチレンβ−ジケトンモノマーを製造するための方法、これらから作られる重合可能な組成物および製品
CN102775399A (zh) * 2011-12-27 2012-11-14 盛世泰科生物医药技术(苏州)有限公司 arylhydrocarbon受体(AHR)的内源性配体,2-(1’H3’-吲哚羰基)噻唑-4-羧酸甲酯的合成新方法
EP2831125B1 (de) 2012-03-30 2016-10-05 Sirrus, Inc. Verfahren zur aktivierung von polymerisierbaren zusammensetzungen, polymerisierbare systeme und damit hergestellte produkte
EP3626784A1 (de) 2012-03-30 2020-03-25 Sirrus, Inc. Tinte und beschichtungsformulierungen sowie polymerisierbare systeme zur herstellung davon
WO2013149168A1 (en) 2012-03-30 2013-10-03 Bioformix, Inc. Composite and laminate articles and polymerizable systems for producing the same
US10047192B2 (en) 2012-06-01 2018-08-14 Sirrus, Inc. Optical material and articles formed therefrom
EP2920231B1 (de) 2012-11-16 2020-05-06 Sirrus, Inc. Kunststoffverbindungssysteme und verfahren
EP3712928A1 (de) 2012-11-30 2020-09-23 Sirrus, Inc. Verbundgemische für elektronikanwendungen
CN105008321A (zh) 2013-01-11 2015-10-28 瑟拉斯公司 经过双(羟甲基)丙二酸酯的途径获得亚甲基丙二酸酯的方法
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
US9217098B1 (en) 2015-06-01 2015-12-22 Sirrus, Inc. Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound
US9518001B1 (en) 2016-05-13 2016-12-13 Sirrus, Inc. High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2062210A5 (de) 1969-09-17 1971-06-25 Godo Shusei Kk
DE2020866A1 (de) 1970-04-29 1971-11-18 Basf Ag Verfahren zur Herstellung von Hydroxy- und Aminobenzonitrilen
DE3002989A1 (de) 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
EP0045281B1 (de) * 1980-07-28 1985-05-08 Ciba-Geigy Ag Thiazolinderivate und Verfahren zu ihrer Herstellung
GB9126832D0 (en) * 1991-12-18 1992-02-19 Sandoz Ltd Separation process
WO1994011367A1 (en) 1992-11-16 1994-05-26 University Of Florida Research Foundation Inc. 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives
US5840739A (en) 1992-11-16 1998-11-24 University Of Florida Research Foundation, Inc. Thiazoline acid derivatives
CA2155130C (en) * 1993-02-26 1994-09-01 Janice M Hitchcock Xanthine derivatives as adenosine a1 receptor antagonists
US5554753A (en) 1993-08-25 1996-09-10 Indiana University Foundation Catalytic enantioselective synthesis of α-amino acid derivatives by phase-transfer catalysis
US6197833B1 (en) * 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5877169A (en) * 1993-11-05 1999-03-02 University Of Florida Research Foundation, Inc. Methods of treatment of ischemic damage
US5859001A (en) * 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
US6350739B1 (en) * 1999-08-11 2002-02-26 University Of Florida Resarch Foundation, Inc. Methods of prevention and treatment of ischemic damage
US6319914B1 (en) * 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5665890A (en) 1995-03-14 1997-09-09 President And Fellows Of Harvard College Stereoselective ring opening reactions
ES2182025T3 (es) * 1996-03-10 2003-03-01 Reuter Chemischer Appbau Kg Procedimiento de separacion.
KR100543151B1 (ko) * 1997-01-16 2006-01-20 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 산화방지제와의 상승적인 상호작용을 통해 폴리시클릭 페놀계화합물의 세포 보호 효과를 증강시키는 조성물
EP1011838B1 (de) 1997-09-06 2006-05-24 Reuter Chemische Apparatebau KG Trennverfahren
JP2004515446A (ja) * 1997-11-24 2004-05-27 ユニバーシティ・オブ・フロリダ・リサーチ・ファンデーション・インコーポレーテッド テストステロン阻害剤及びニューロンの保護のためのその用途
WO1999036399A1 (en) * 1998-01-13 1999-07-22 Kaneka Corporation Process for producing optically active cysteine derivatives
US5929252A (en) * 1998-06-15 1999-07-27 The Scripps Research Institute Aziridination of olefins
US6765109B1 (en) * 1998-06-29 2004-07-20 Roche Colorado Corporation Preparation of S-aryl-cysteine and its derivatives
AU4856199A (en) 1998-07-03 2000-01-24 Millennium Pharmaceuticals, Inc. Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US6159983A (en) * 1998-09-18 2000-12-12 University Of Florida Method and composition for treatment of inflammatory bowel disease
NZ509172A (en) 1998-09-21 2004-02-27 Univ Florida Antimalarial agents
CN100453531C (zh) * 1998-10-09 2009-01-21 味之素株式会社 半胱氨酸衍生物
US6326365B1 (en) * 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6339078B1 (en) * 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
DE20000122U1 (de) * 2000-01-05 2000-04-20 ABT Advanced Bioanalytical Technology GmbH & Co KG, 01454 Radeberg Mobiles Handgerät mit wiederverwendbarem Biosensor
AU3033700A (en) 2000-01-14 2001-07-24 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AT500490A1 (de) 2001-10-16 2006-01-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von substituierten thiazolinen und deren zwischenprodukte
US6794515B2 (en) * 2002-05-15 2004-09-21 Genzyme Corporation Synthesis of 2-alkylcysteine via substituted thiazoline amide
ITVR20020062A1 (it) * 2002-06-03 2003-12-03 Andrea Pretto Preparazione estemporanea di periossiacidi organici stabili nel tempo

Also Published As

Publication number Publication date
US7285670B2 (en) 2007-10-23
US20040006224A1 (en) 2004-01-08
US20030220504A1 (en) 2003-11-27
US20040024224A1 (en) 2004-02-05
US20030225287A1 (en) 2003-12-04
US20030236434A1 (en) 2003-12-25
US20030236426A1 (en) 2003-12-25
JP2005538950A (ja) 2005-12-22
US20040002613A1 (en) 2004-01-01
US6846958B2 (en) 2005-01-25
US7294718B2 (en) 2007-11-13
US20060142586A1 (en) 2006-06-29
US20060167267A1 (en) 2006-07-27
WO2003097622A3 (en) 2004-04-08
WO2003097582A2 (en) 2003-11-27
US20030236404A1 (en) 2003-12-25
US6903220B2 (en) 2005-06-07
US20030236435A1 (en) 2003-12-25
US6794515B2 (en) 2004-09-21
AU2003247374A8 (en) 2003-12-02
JP2007001986A (ja) 2007-01-11
US7576234B2 (en) 2009-08-18
AU2003239472A1 (en) 2003-12-02
WO2003097622A2 (en) 2003-11-27
EP1506162A2 (de) 2005-02-16
EP1529037A2 (de) 2005-05-11
EP1529037B1 (de) 2009-07-15
US6875883B2 (en) 2005-04-05
US7115769B2 (en) 2006-10-03
WO2003097582A3 (en) 2004-02-12
JP2005525427A (ja) 2005-08-25
JP4414331B2 (ja) 2010-02-10
US7038073B2 (en) 2006-05-02
US7285676B2 (en) 2007-10-23
US20030229231A1 (en) 2003-12-11
US6878828B2 (en) 2005-04-12
US6875882B2 (en) 2005-04-05
US20060069265A1 (en) 2006-03-30
AU2003247374A1 (en) 2003-12-02
US20040082796A1 (en) 2004-04-29
US20060217561A1 (en) 2006-09-28
US6861532B2 (en) 2005-03-01
US20060281926A1 (en) 2006-12-14
US20050209462A1 (en) 2005-09-22
EP1506162B1 (de) 2008-11-26
US7002036B2 (en) 2006-02-21
US6982335B2 (en) 2006-01-03

Similar Documents

Publication Publication Date Title
ATE415387T1 (de) Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten
DE60210772D1 (de) Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen der familie enterobacteriaceae
ATE426403T1 (de) Photosensibilisator und verfahren zu seiner herstellung
PT1041072E (pt) Acidos dioxociclopentil hidroxamicos
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
DE60118241D1 (de) Verfahren zur herstellung von oxazolidinonverbindungen
PE20060692A1 (es) Inhibidores bace
DE69931753D1 (de) Azoverbindungen sowie verfahren zur herstellung derselben
PE20020294A1 (es) Derivados de pirrolidina como inhibidores de la enzima conversor de endotelina
MXPA04000357A (es) COMPUESTO QUE CONTIENE AMIDA Y TIENE UNA MEJOR SOLUBILIDAD, Y MeTODO PARA MEJORAR LA SOLUBILIDAD DE UN COMPUESTO QUE CONTIENE AMIDA.
DE60115954D1 (de) Verfahren zur herstellung von gabapentin
DE60205955D1 (de) Verfahren zur Herstellung von L-Aminosäuren
DE60131733D1 (de) Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga
BR0010225A (pt) Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso
DK1309535T3 (da) Fremgangsmåder til fremstilling af alfa'-chlorketoner
ATE355296T1 (de) Verfahren zur herstellung von (e,z) 3-(2- aminoethoxyimino)-androstane-6,17-dione und analoge
DE50309260D1 (de) Verfahren zur herstellung von bicalutamid
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60040592D1 (de) Verfahren zur herstellung von alpha-aminoketonen
HUP9802146A2 (hu) Eljárás optikailag aktív 2-amino-omega-oxoalkánsav-származékok előállítására és a vegyületek
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
EP1244610A4 (de) Verbessertes verfahren zur herstellung von 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
ATE258161T1 (de) Verfahren zur herstellung von chiralen aminosäuren
ATE281522T1 (de) Sentrin-spezifische menschliche protease senp1
DE602007003312D1 (de) Verfahren zur Herstellung von (2r,3s)-3-Phenylisoserin-Methylester-Acetatsalz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties